From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves abiraterone for metastatic prostate cancer

from Medscape

The U.S. Food and Drug Administration (FDA) has approved abiraterone acetate (Zytiga, Cougar Biotechnology) in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer in men who have received prior docetaxel chemotherapy. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063